Outlook Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Sep 2014 | — | — | $2.3M |
| Mar 2015 | — | — | $425.8K |
| Jun 2015 | — | — | $5.4M |
| Sep 2015 | $62.6M | $35.0M | $9.1M |
| Dec 2015 | — | — | $5.6M |
| Mar 2016 | $45.3M | $24.8M | $2.8M |
| Jun 2016 | $31.4M | $33.0M | $13.6M |
| Sep 2016 | $30.6M | $25.4M | $2.4M |
| Dec 2016 | $42.3M | $20.4M | $2.1M |
| Mar 2017 | $44.3M | $17.5M | $81.0K |
| Jun 2017 | $46.1M | $17.1M | $139.9K |
| Sep 2017 | $51.5M | $20.7M | $3.2M |
| Dec 2017 | $40.2M | $32.3M | $13.8M |
| Mar 2018 | $43.1M | $27.8M | $5.9M |
| Jun 2018 | $43.4M | $34.1M | $11.8M |
| Sep 2018 | $43.1M | $22.3M | $1.7M |
| Dec 2018 | $40.2M | $18.7M | $227.7K |
| Mar 2019 | $40.2M | $17.2M | $155.5K |
| Jun 2019 | $34.6M | $33.2M | $14.0M |
| Sep 2019 | $27.9M | $17.1M | $8.0M |
| Dec 2019 | $35.8M | $10.4M | $1.3M |
| Mar 2020 | $33.7M | $13.2M | $4.7M |
| Jun 2020 | $19.3M | $30.2M | $24.0M |
| Sep 2020 | $16.9M | $19.7M | $12.5M |
| Dec 2020 | $23.0M | $12.5M | $5.6M |
| Mar 2021 | $24.5M | $45.1M | $37.2M |
| Jun 2021 | $20.1M | $32.9M | $19.7M |
| Sep 2021 | $18.2M | $22.8M | $14.5M |
| Dec 2021 | $29.9M | $78.7M | $70.2M |
| Mar 2022 | $31.7M | $67.7M | $58.4M |
| Jun 2022 | $18.5M | $38.6M | $26.0M |
| Sep 2022 | $19.8M | $28.5M | $17.4M |
| Dec 2022 | $46.9M | $62.7M | $52.3M |
| Mar 2023 | $43.5M | $54.0M | $43.6M |
| Jun 2023 | $50.0M | $44.4M | $33.7M |
| Sep 2023 | $46.7M | $32.3M | $23.4M |
| Dec 2023 | $46.0M | $21.7M | $10.4M |
| Mar 2024 | $193.3M | $59.0M | $47.2M |
| Jun 2024 | $130.8M | $47.1M | $32.0M |
| Sep 2024 | $101.9M | $28.8M | $14.9M |
| Dec 2024 | $67.3M | $17.0M | $5.7M |
| Mar 2025 | $51.5M | $19.1M | $7.6M |
| Jun 2025 | $59.6M | $22.4M | $8.9M |
| Sep 2025 | $50.8M | $18.6M | $8.1M |
| Dec 2025 | $56.8M | $18.2M | $8.7M |
| Mar 2026 | $50.9M | $21.9M | $7.7M |
| Jun 2026 | $36.6M | $26.2M | $11.2M |